APA (7th ed.) Citation

C, R., A, S., A, B., P, G., S, B., G, B., . . . J, G. (2025). Development and Validation of a LC-MS/MS Method for Ripretinib and Its Metabolite: Example of a Journey From Laboratory Bench to Routine Application With a Greenness Assessment. Biomedical chromatography : BMC, 39(9), e70190. https://doi.org/10.1002/bmc.70190

Chicago Style (17th ed.) Citation

C, Rakotovao, et al. "Development and Validation of a LC-MS/MS Method for Ripretinib and Its Metabolite: Example of a Journey From Laboratory Bench to Routine Application With a Greenness Assessment." Biomedical Chromatography : BMC 39, no. 9 (2025): e70190. https://doi.org/10.1002/bmc.70190.

MLA (9th ed.) Citation

C, Rakotovao, et al. "Development and Validation of a LC-MS/MS Method for Ripretinib and Its Metabolite: Example of a Journey From Laboratory Bench to Routine Application With a Greenness Assessment." Biomedical Chromatography : BMC, vol. 39, no. 9, 2025, p. e70190, https://doi.org/10.1002/bmc.70190.